Treatment of hormone-refractory prostate cancer, HRPC, remains challenging.
Weroha
S John
SJ
Quevedo
J Fernando
JF
D003520:Cyclophosphamide / Q000494:pharmacology / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy*; D016896:Treatment Outcome
D003520:Cyclophosphamide